Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 407-950-9 | CAS number: 895-85-2 INTEROX-PMBP-70W; INTEROX-PMPB-70W
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Bis(4-methylbenzoyl)peroxide, 75% in water CAS No. 895-85-2:Oral (Gavage) Reproduction/Developmental Toxicity Screening Test in the Rat (OECD 421):
Introduction
The study was performed to screen for potential adverse effects of the test item on reproduction, including offspring development, and provides an initial hazard assessment for effect on reproduction. The study is compatible with the requirements of the recommendations of the OECD Guidelines for Testing of Chemicals No. 421 “Reproduction/Developmental Toxicity Screening Test” (adopted 27 July 1995).
This study was also designed to be compatible with Commission Regulation (EC) No 440/2008 of 30 May 2008 test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).
Methods…….
The test item was administered by gavage to three groups, each of twelve male and twelve female Wistar Han™:RccHan™:WIST strain rats, for up to eight weeks (including a two week pre-pairing phase, pairing, gestation and early lactation for females), at dose levels of 50, 200 and 1000 mg/kg bw/day. A control group of twelve males and twelve females was dosed with vehicle alone (Polyethylene glycol 400).
Clinical signs, body weight change, dietary intake and water consumption were monitored during the study.
Pairing of animals within each dose group was undertaken on a one male: one female basis within each treatment group on Day 15 of the study, with females subsequently being allowed to litter and rear their offspring to Day 5 of lactation.
During the lactation phase, daily clinical observations were performed on all surviving offspring, together with litter size and offspring weights and assessment of surface righting reflex.
Adult males were euthanized on Day 43, followed by the euthanization of all surviving females and offspring on Day 5post partum. Any female which did not produce a pregnancy was euthanized on or after Day 25post coitum. All animals were subjected to a gross necropsy examination and histopathological evaluation of reproductive tissues was performed.
Results…….
Adult Responses
Mortality
There were no deaths that were considered to be related to treatment.
Clinical Observations
No toxicologically significant clinical signs were detected in treated animals.
Body Weight
There were no treatment-related effects on body weight development.
Food Consumption
No adverse effects on dietary intake were noted for males during the study or for females during the pre-pairing, gestation or lactation phases of the study.
Water Consumption
No adverse effect on water consumption was evident in treated animals when compared to controls.
Reproductive Performance
Mating
No treatment-related effects were detected in mating performance. One control female showed positive evidence of mating but was non pregnant.
Fertility
There were no treatment-related differences in fertility.
Gestation Length
Gestation lengths were between 22 and 23½ days and the distribution of gestation lengths for treated females was essentially similar to control.
Litter Responses
Offspring Litter Size, Sex Ratio and Viability
Of the litters born, litter size at birth and subsequently on Days 1 and 4post partumwere comparable to controls. Sex ratio in treated litters was comparable to controls.
Offspring Growth and Development
Offspring body weight gain and litter weights at birth and subsequently on Days 1 and 4 post partum were comparable to controls. Surface righting in treated litters was comparable to controls.
Offspring Observations
The clinical signs and necropsy findings apparent for offspring on the study were typical for the age observed. Neither the incidence nor distribution of these observations indicated any adverse effect of maternal treatment on offspring development at 50, 200 or 1000 mg/kg bw/day.
Pathology
Necropsy
No macroscopic abnormalities were detected.
Organ Weights
No treatment-related changes were evident in the organ weights measured.
Histopathology
No treatment-related microscopic abnormalities were detected.
Conclusion
The oral administration of bis(4-methylbenzoyl)peroxide, 75% in water CAS No. 895-85-2 to rats by gavage, at dose levels of 50, 200 and 1000 mg/kg bw/day, did not result in any treatment-related effects or treatment-related adverse effects.
The ‘No Observed Effect Level’ (NOEL) for reproductive and developmental toxicity was considered to be 1000 mg/kg bw/day.
Short description of key information:
It was concluded that the NOEL for reproductive toxicity is 1000
mg/kg/d.
Justification for selection of Effect on fertility via oral route:
Well-conducted GLP study.
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental start date: July 2nd 2014 Experimental completion date: 19th January 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- A sufficient number of male and female Wistar Han™:RccHan™:WIST strain rats were obtained from Harlan Laboratories U.K. Ltd., Blackthorn, Bicester, Oxon, UK. On receipt the animals were examined for signs of ill-health or injury. The animals were acclimatized for five days during which time their health status was assessed. A total of ninety six animals (forty eight males and forty eight females) were accepted into the study. At the start of treatment the males weighed 301 to 340g, the females weighed 198 to 239g, and were approximately twelve weeks old.
Initially, all animals were housed in groups of four in solid floor polypropylene cages with stainless steel mesh lids and softwood flake bedding (Datesand Ltd., Cheshire, UK). During the pairing phase, the animals were transferred to polypropylene grid floor cages suspended over trays lined with absorbent paper on a one male: one female basis. Following evidence of successful mating, the males were returned to their original cages. Mated females were housed individually during gestation and lactation in solid floor polypropylene cages with stainless steel mesh lids and softwood flakes.
The animals were allowed free access to food and water. A pelleted diet (Rodent 2018C Teklad Global Certified Diet, Harlan Laboratories U.K. Ltd., Oxon, UK.) was used. Certificates of analysis of the batches of diet used are given in Appendix 22. Mains drinking water was supplied from polycarbonate bottles attached to the cage. Environmental enrichment was provided in the form of wooden chew blocks and cardboard fun tunnels (Datesand Ltd., Cheshire, UK) except for paired animals and mated females during final week of gestation and lactation. Mated females were also given softwood flakes, as bedding, throughout gestation and lactation. The diet, drinking water, bedding and environmental enrichment were considered not to contain any contaminant at a level that might have affected the purpose or integrity of the study.
The animals were housed in a single air-conditioned room within the Harlan Laboratories Ltd., Shardlow, UK Barrier Maintained Rodent Facility. The rate of air exchange was at least fifteen air changes per hour (see deviations from Study Plan) and the low intensity fluorescent lighting was controlled to give twelve hours continuous light and twelve hours darkness. Environmental conditions were continuously monitored by a computerized system, and print-outs of hourly temperatures and humidities are included in the study records. The Study Plan target ranges for temperature and relative humidity were 22 ± 3 °C and 50 ± 20% respectively. Short term deviations from these targets were considered not to have affected the purpose or integrity of the study; see deviations from Study Plan.
The animals were randomly allocated to treatment groups using a stratified body weight randomization procedure and the group mean body weights were then determined to ensure similarity between the treatment groups. The cage distribution within the holding rack was also randomized. The animals were uniquely identified within the study by an ear punching system routinely used in these laboratories. - Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Details on exposure:
- For the purpose of this study the test item was prepared at the appropriate concentrations as a suspension in Polyethylene glycol 400. The stability and homogeneity of the test item formulations were determined by Harlan Laboratories Ltd., Shardlow, UK, Analytical Services. Results show the formulations to be stable for at least nineteen days. Formulations were initially prepared daily for the first week, weekly for the second and final week and fortnighlty for the remaining weeks. All formulations were stored at approximately 4 °C in the dark.
Samples of the test item formulation were taken and analyzed for concentration of bis(4-methylbenzoyl)peroxide, 75% CAS No. 895-85-2 in water at Harlan Laboratories Ltd., Shardlow, UK, Analytical Services. The results indicate that the prepared formulations were within ± 6% of the nominal concentration. - Details on mating procedure:
- i. Groups of twelve male and twelve female animals were treated daily at the appropriate dose level throughout the study (except for females during parturition where applicable). The first day of dosing was designated as Day 1 of the study.
ii. On Day 15, animals were paired on a 1 male: 1 female basis within each dose group for a maximum of fourteen days.
iii. Following evidence of mating (designated as Day 0 post coitum) the males were returned to their original cages and females were transferred to individual cages. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The test item concentration in the test samples was determined by high performance liquid chromatography with UV detection (HPLC/UV) using an external standard technique. The test item gave a chromatographic profile of a single peak.
Instrumental Setup
HPLC: Agilent Technologies 1200, incorprating autosampler and workstation
Column: Zorbax Eclipse XDB C18 (150 x 4.6 mm id)
Column temp: 40°C
Mobile phase: Acetonotrile:water (90:10 v/v)
Flow-rate: 1 mL/min
UV detector wavelength: 252 nm
Injection volume: 5 microL
Retention time: ~3 mins
Study samples and storage
Representative samples were dispatched to the analytical laboratories internally (under vambient conditions) and stored at room temperature until analysis.
Discussion
The detection system was found to have acceptable linearity. The analytical procedure ahd acceptable recoveries of test item in the vehicle. The method of analysis was validated and proved to be suitable for use. - Duration of treatment / exposure:
- Females: Until Day 5 post-partum
Males: 42 days - Frequency of treatment:
- The test item was administered daily by gavage using a stainless steel cannula attached to a disposable plastic syringe. Control animals were treated in an identical manner with 4 mL/kg of Polyethylene glycol 400.
- Details on study schedule:
- Chronological Sequence of Study
i. Groups of twelve male and twelve female animals were treated daily at the appropriate dose level throughout the study (except for females during parturition where applicable). The first day of dosing was designated as Day 1 of the study.
ii. On Day 15, animals were paired on a 1 male: 1 female basis within each dose group for a maximum of fourteen days.
iii. Following evidence of mating (designated as Day 0 post coitum) the males were returned to their original cages and females were transferred to individual cages.
iv. Pregnant females were allowed to give birth and maintain their offspring until Day 5 post partum. Litter size, offspring weight and sex, surface righting and clinical signs were also recorded during this period.
v. The male dose groups were euthanized and examined macroscopically on Day 43.
vi. At Day 5 post partum, all surviving females and offspring were euthanized and examined macroscopically. - Remarks:
- Doses / Concentrations:
0 mg/kg bw/day
Basis:
actual ingested
Control. - Remarks:
- Doses / Concentrations:
50 mg/kg bw/day
Basis:
actual ingested
Concentration: 12.5 mg/mL - Remarks:
- Doses / Concentrations:
200 mg/kg bw/day
Basis:
actual ingested
Concentration: 50 g/mL - Remarks:
- Doses / Concentrations:
1000mg/kg bw/day
Basis:
actual ingested
Concentration: 250 mg/mL - No. of animals per sex per dose:
- 12 males, 12 females per dose group (including Control)
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- The animals were randomly allocated to treatment groups using a stratified body weight randomization procedure and the group mean body weights were then determined to ensure similarity between the treatment groups. The cage distribution within the holding rack was also randomized. The animals were uniquely identified within the study by an ear punching system routinely used in these laboratories.
- Positive control:
- Not applicable
- Parental animals: Observations and examinations:
- Clinical Observations
All animals were examined for overt signs of toxicity, ill-health and behavioral change immediately before dosing, soon after dosing, and one hour after dosing (except for females during parturition where applicable). All observations were recorded.
Body Weight
Individual body weights were recorded on Day 1 (prior to dosing) and then weekly for males until termination and weekly for females until pairing. During the pairing phase females were weighed daily until mating was confirmed. Body weights were then recorded for females on Days 0, 7, 14 and 20 post coitum, and on Days 1 and 4 post partum.
Food Consumption
During the pre-pairing period, weekly food consumption was recorded for each cage of adults until pairing. This was continued for males after the mating phase. For females showing evidence of mating, food consumption was recorded for the periods covering post coitum Days 0-7, 7-14 and 14-20. For females with live litters, food consumption was recorded during the lactation period (Days 1-4).
Weekly food efficiency (body weight gain/food intake) was calculated retrospectively for males and for females during the pre-pairing phase. Due to offspring growth and milk production for lactation, food efficiency for females could not be accurately calculated during gestation and lactation.
Water Consumption
Water intake was observed daily by visual inspection of water bottles for any overt changes.
Reproductive Performance
Mating
Animals were paired on a 1 male: 1 female basis within each dose group, for a period of up to fourteen days. Cage tray-liners were checked each morning for the presence of ejected copulation plugs and each female was examined for the presence of a copulation plug in the vagina. A vaginal smear was prepared for each female and the stage of oestrus or the presence of sperm was recorded. The presence of sperm within the vaginal smear and/or vaginal plug in situ was taken as positive evidence of mating (Day 0 of gestation) and the males were subsequently returned to their original holding cages. Mated females were housed individually during the period of gestation and lactation. - Oestrous cyclicity (parental animals):
- Pregnancy and Parturition
Each pregnant female was observed at approximately 0830, 1230 and 1630 hours and around the period of expected parturition. Observations were carried out at approximately 0830 and 1230 hours at weekends and public holidays. The following was recorded for each female:
i. Date of pairing
ii. Date of mating
iii. Date and time of observed start of parturition
iv. Date and time of observed completion of parturition - Sperm parameters (parental animals):
- The epididymides and testes were removed from terminal kill adult males dissected free from fat and weighed before fixation.
- Litter observations:
- On completion of parturition (Day 0 post partum), the number of live and dead offspring was recorded. Offspring were individually identified within each litter by tattoo on Day 1 post partum.
For each litter the following was recorded:
i. Number of offspring born
ii. Number of offspring alive recorded daily and reported on Days 1 and 4 post partum
iii. Sex of offspring on Days 1 and 4 post partum
iv. Clinical condition of offspring from birth to Day 5 post partum
v. Individual offspring weights on Days 1 and 4 post partum (litter weights were calculated retrospectively from this data)
Physical Development
All live offspring were assessed for surface righting reflex on Day 1 post partum - Postmortem examinations (parental animals):
- Adult males were euthanized by intravenous overdose of a suitable barbiturate agent followed by exsanguination on Day 43. Surviving adult females were euthanized by intravenous overdose of a suitable barbiturate agent followed by exsanguination on Day 5 post partum. Surviving offspring were euthanized via intracardiac overdose of a suitable barbiturate agent. Any females which failed to achieve pregnancy or produce a litter were euthanized on or after Day 25 post coitum.
For all females, the uterus was examined for signs of implantation and the number of uterine implantations in each horn was recorded. This procedure was enhanced; as necessary, by staining the uteri with a 0.5% ammonium polysulphide solution (Salewski 1964). The corpora lutea were also counted.
All adult animals and offspring, including those dying during the study, were subjected to a full external and internal examination, and any macroscopic abnormalities were recorded.
Histopathology
Samples of the following tissues were preserved from all animals from each dose group, in buffered 10% formalin, except where stated:
Coagulating gland, Prostate, Epididymides ♦, Seminal vesicles, Ovaries, Testes ♦, Mammary gland (females only), Uterus/Cervix, Pituitary, Vagina
All tissues were dispatched to the histology processing Test Site (Propath UK Ltd, Willow Court, Netherwood Road, Rotherwas, Hereford, HR2 6JU) for processing. The tissues from control and 1000 mg/kg bw/day dose group animals, and any animals which did not achieve a pregnancy were prepared as paraffin blocks, sectioned at a nominal thickness of 5 μm and stained with Hematoxylin and Eosin for subsequent microscopic examination. In addition, sections of testes from all control and 1000 mg/kg bw/day males were also stained with Periodic Acid-Schiff (PAS) stain and examined.
Detailed qualitative examination of the testes was undertaken, taking into account the tubular stages of the spermatogenic cycle. The examination was conducted in order to identify treatment-related effects such as missing germ cell layers or types, retained spermatids, multinucleated or apoptotic germ cells and sloughing of spermatogenic cells into the lumen. Any cell or stage specificity of testicular findings was noted.
Microscopic examination was conducted by the Study Pathologist (Roger Alison Ltd, Caerfyrddin Fach, Cilcennin, Lampeter, SA48 8RN, United Kingdom). - Postmortem examinations (offspring):
- All adult animals and offspring, including those dying during the study, were subjected to a full external and internal examination, and any macroscopic abnormalities were recorded.
- Statistics:
- Please refer to the section below, "Any other information on materials and methods)
- Reproductive indices:
- Mating Performance and Fertility
The following parameters were calculated from the individual data during the mating period of the parental generation:
i. Pre-coital Interval - Calculated as the time elapsing between initial pairing and the observation of positive evidence of mating.
ii. Fertility Indices - For each group the following were calculated:
Mating Index (%) = (Number of animals mated / Number of animals paired) x 100
Pregnancy Index (%) = (Number of pregnant females / number of animals mated) x 100
Gestation and Parturition Data
The following parameters were calculated from individual data during the gestation and parturition period of the parental generation:
i. Gestation Length
Calculated as the number of days of gestation including the day for observation of mating and the start of parturition.
ii. Parturition Index
The following was calculated for each group:
Parturition Index (%) = (Number of females delivering live offspring / Number of pregnant females) x 100 - Offspring viability indices:
- Litter Responses
The standard unit of assessment was considered to be the litter, therefore values were first calculated for each litter and the group mean was calculated using their individual litter values. Group mean values included all litters reared to termination (Day 5 of age).
i. Implantation Losses (%)
Group mean percentile pre-implantation and post-implantation loss were calculated for each female/litter as follows:
Pre–implantation loss (%) = ((Number of corpora lutea - Number of implantation sites) / Number of corpora lutea) x100
Post–implantation loss (%) = ((Number of implantation sites - Total number of offspring born) / Number of implantation sites) x 100
ii. Live Birth and Viability Indices
The following indices were calculated for each litter as follows:
Live Birth Index (%) = (Number of offspring alive on Day 1 / Number of offpsring born) x 100
Viability Index (%) = (Number of offsoring alive on Day 4 / Number of offspring alive on Day 1) x 100
iii. Sex Ratio (% males)
Sex ratio was calculated for each litter value on Days 1 and 4 post partum, using the following formula:
(Number of male offspring / Total number if offspring) x 100 - Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Other effects:
- not examined
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
- Dose descriptor:
- NOEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: The oral administration of bis(4-methylbenzoyl)peroxide, 75% in water CAS No. 895-85-2 to rats by gavage, at dose levels of 50, 200 and 1000 mg/kg bw/day, did not result in any treatment-related effects.
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not examined
- Dose descriptor:
- NOEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: The oral administration of bis(4-methylbenzoyl)peroxide, 75% in water CAS No. 895-85-2 to rats by gavage, at dose levels of 50, 200 and 1000 mg/kg bw/day, did not result in any treatment-related effects.
- Reproductive effects observed:
- not specified
- Conclusions:
- The oral administration of bis(4-methylbenzoyl)peroxide, 75% in water CAS No. 895-85-2 to rats by gavage, at dose levels of 50, 200 and 1000 mg/kg bw/day, did not result in any treatment-related effects.
The ‘No Observed Effect Level’ (NOEL) for reproductive and developmental toxicity was considered to be 1000 mg/kg bw/day. - Executive summary:
Introduction
The study was performed to screen for potential adverse effects of the test item on reproduction, including offspring development, and provides an initial hazard assessment for effect on reproduction. The study is compatible with the requirements of the recommendations of the OECD Guidelines for Testing of Chemicals No. 421 “Reproduction/Developmental Toxicity Screening Test” (adopted 27 July 1995).
This study was also designed to be compatible with Commission Regulation (EC) No 440/2008 of 30 May 2008 test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).
Methods…….
The test item was administered by gavage to three groups, each of twelve male and twelve female Wistar Han™:RccHan™:WIST strain rats, for up to eight weeks (including a two week pre-pairing phase, pairing, gestation and early lactation for females), at dose levels of 50, 200 and 1000 mg/kg bw/day. A control group of twelve males and twelve females was dosed with vehicle alone (Polyethylene glycol 400).
Clinical signs, body weight change, dietary intake and water consumption were monitored during the study.
Pairing of animals within each dose group was undertaken on a one male: one female basis within each treatment group on Day 15 of the study, with females subsequently being allowed to litter and rear their offspring to Day 5 of lactation.
During the lactation phase, daily clinical observations were performed on all surviving offspring, together with litter size and offspring weights and assessment of surface righting reflex.
Adult males were euthanized on Day 43, followed by the euthanization of all surviving females and offspring on Day 5post partum. Any female which did not produce a pregnancy was euthanized on or after Day 25post coitum. All animals were subjected to a gross necropsy examination and histopathological evaluation of reproductive tissues was performed.
Results…….
Adult Responses
Mortality
There were no deaths that were considered to be related to treatment.
Clinical Observations
No toxicologically significant clinical signs were detected in treated animals.
Body Weight
There were no treatment-related effects on body weight development.
Food Consumption
No adverse effects on dietary intake were noted for males during the study or for females during the pre-pairing, gestation or lactation phases of the study.
Water Consumption
No adverse effect on water consumption was evident in treated animals when compared to controls.
Reproductive Performance
Mating
No treatment-related effects were detected in mating performance. One control female showed positive evidence of mating but was non pregnant.
Fertility
There were no treatment-related differences in fertility.
Gestation Length
Gestation lengths were between 22 and 23½ days and the distribution of gestation lengths for treated females was essentially similar to control.
Litter Responses
Offspring Litter Size, Sex Ratio and Viability
Of the litters born, litter size at birth and subsequently on Days 1 and 4post partumwere comparable to controls. Sex ratio in treated litters was comparable to controls.
Offspring Growth and Development
Offspring body weight gain and litter weights at birth and subsequently on Days 1 and 4 post partum were comparable to controls. Surface righting in treated litters was comparable to controls.
Offspring Observations
The clinical signs and necropsy findings apparent for offspring on the study were typical for the age observed. Neither the incidence nor distribution of these observations indicated any adverse effect of maternal treatment on offspring development at 50, 200 or 1000 mg/kg bw/day.
Pathology
Necropsy
No macroscopic abnormalities were detected.
Organ Weights
No treatment-related changes were evident in the organ weights measured.
Histopathology
No treatment-related microscopic abnormalities were detected.
Conclusion
The oral administration of bis(4-methylbenzoyl)peroxide, 75% in water CAS No. 895-85-2 to rats by gavage, at dose levels of 50, 200 and 1000 mg/kg bw/day, did not result in any treatment-related effects.
The ‘No Observed Effect Level’ (NOEL) for reproductive and developmental toxicity was considered to be 1000 mg/kg bw/day.
Reference
Mortality
There were no deaths that were considered to be related to treatment.
One female treated with 1000 mg/kg bw/day was found dead shortly after smearing on Day 21. This female had not shown any clinical signs prior to Day 21, no effect on body weight gain and no macroscopic or microscopic abnormalities were evident. This death was therefore considered to be incidental and not related to treatment.
Clinical Observations
There were no toxicologically significant clinical signs evident in treated animals.
Two males treated with 1000 mg/kg bw/day and one male treated with 50 mg/kg bw/day showed isolated incidents of increased salivation on Day 29 and 30 (respectively). One female treated with 1000 mg/kg bw/day had noisy respiration on Day 36 and one female treated with 200 mg/kg bw/day had generalised fur loss between Days 21 and 44.
Body Weight
There were no treatment-related effects on body weight development.
Females treated with 1000 and 50 mg/kg bw/day showed a statistically significant increase in body weight on Day 4 of lactation. An increase in body weight or body weight gain is not considered to represent an adverse effect of treatment therefore the intergroup differences were considered not to be toxicologically important.
Food Consumption
No adverse effects on dietary intake were noted for males during the study or for females during the pre-pairing, gestation or lactation phases of the study.
Statistical analysis of the data for females during gestation and lactation did not reveal any significant intergroup differences.
Water Consumption
No adverse effect on water consumption was evident in treated animals when compared to controls.
Reproductive Performance
Mating
No treatment-related effects were detected in mating performance.
One control female showed positive evidence of mating but was non pregnant. No histopathological abnormalities were observed to explain the failure of this animal to breed successfully.
Fertility
There were no treatment-related differences in fertility.
One female treated with 50 mg/kg bw/day showed positive evidence of mating but failed to give birth to any live offspring. No histopathological abnormalities were observed to explain the failure of this animal to breed successfully and in the absence of a similar effect at 1000 mg/kg bw/day this was considered incidental and unrelated to treatment.
Gestation Length
Gestation lengths were between 22 and 23½ days and the distribution of gestation lengths for treated females was essentially similar to control.
No macroscopic abnormalities were detected.
Organ Weights
No treatment-related changes were evident in the organ weights measured.
Statistical analysis of the data did not reveal any significant intergroup differences.
Histopathology
No treatment-related microscopic abnormalities were detected.
In total eleven females from the control, 50 and 1000 mg/kg bw/day dose groups and twelve females from the 200 mg/kg bw/day dose group gave birth to a live litter and successfully reared young to Day 5 of age. The following assessment of litter response is based on all litters reared to termination on Day 5 of lactation/age.
Offspring Litter Size, Sex Ratio and Viability
No significant differences were detected for corpora lutea, implantation counts, implantation losses, litter size or litter viability for treated animals when compared to controls. Statistical analysis of the data did not reveal any significant intergroup differences.
There were no intergroup differences in sex ratio (percentage male offspring) for litters from treated groups compared to controls. Statistical analysis of the data did not reveal any significant intergroup differences.
Offspring Growth and Development
There were no toxicologically significant effects detected.
Statistical analysis of the litter, offspring weights or surface righting reflex data did not reveal any significant intergroup differences.
No obvious clinical signs of toxicity were detected for offspring from treated females when compared to controls. The incidental clinical signs detected throughout the control and treated groups, consisting of small size, cold, physical injury, bruising or scab formation were considered to be low incidence findings observed in offspring in studies of this type and were considered unrelated to test item toxicity.
No treatment-related macroscopic abnormalities were detected for offspring. The incidental findings observed were those occasionally observed in reproductive studies of this type and were considered to be unrelated to toxicity of the test item.
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- K1 rating. A well-conducted GLP study.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Effects on developmental toxicity
Description of key information
It was concluded that the NOEL for developmental toxicity is 1000 mg/kg/d.
Link to relevant study records
- Endpoint:
- developmental toxicity
- Remarks:
- screening study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Experimental starting date: July 2nd 2014 Experimental completion date: January 19th 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results.
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guidelines for Testing of Chemicals No. 421 "Reproduction/Developmental Toxicity Screening Test"
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- A sufficient number of male and female Wistar Han™:RccHan™:WIST strain rats were obtained from Harlan Laboratories U.K. Ltd., Blackthorn, Bicester, Oxon, UK. On receipt the animals were examined for signs of ill-health or injury. The animals were acclimatized for five days during which time their health status was assessed. A total of ninety six animals (forty eight males and forty eight females) were accepted into the study. At the start of treatment the males weighed 301 to 340g, the females weighed 198 to 239g, and were approximately twelve weeks old.
Initially, all animals were housed in groups of four in solid floor polypropylene cages with stainless steel mesh lids and softwood flake bedding (Datesand Ltd., Cheshire, UK). During the pairing phase, the animals were transferred to polypropylene grid floor cages suspended over trays lined with absorbent paper on a one male: one female basis. Following evidence of successful mating, the males were returned to their original cages. Mated females were housed individually during gestation and lactation in solid floor polypropylene cages with stainless steel mesh lids and softwood flakes.
The animals were allowed free access to food and water. A pelleted diet (Rodent 2018C Teklad Global Certified Diet, Harlan Laboratories U.K. Ltd., Oxon, UK.) was used. Certificates of analysis of the batches of diet used are given in Appendix 22. Mains drinking water was supplied from polycarbonate bottles attached to the cage. Environmental enrichment was provided in the form of wooden chew blocks and cardboard fun tunnels (Datesand Ltd., Cheshire, UK) except for paired animals and mated females during final week of gestation and lactation. Mated females were also given softwood flakes, as bedding, throughout gestation and lactation. The diet, drinking water, bedding and environmental enrichment were considered not to contain any contaminant at a level that might have affected the purpose or integrity of the study.
The animals were housed in a single air-conditioned room within the Harlan Laboratories Ltd., Shardlow, UK Barrier Maintained Rodent Facility. The rate of air exchange was at least fifteen air changes per hour (see deviations from Study Plan) and the low intensity fluorescent lighting was controlled to give twelve hours continuous light and twelve hours darkness. Environmental conditions were continuously monitored by a computerized system, and print-outs of hourly temperatures and humidities are included in the study records. The Study Plan target ranges for temperature and relative humidity were 22 ± 3 °C and 50 ± 20% respectively. Short term deviations from these targets were considered not to have affected the purpose or integrity of the study; see deviations from Study Plan.
The animals were randomly allocated to treatment groups using a stratified body weight randomization procedure and the group mean body weights were then determined to ensure similarity between the treatment groups. The cage distribution within the holding rack was also randomized. The animals were uniquely identified within the study by an ear punching system routinely used in these laboratories. - Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Details on exposure:
- For the purpose of this study the test item was prepared at the appropriate concentrations as a suspension in Polyethylene Glycol 400. The stability and homogeneity of the test item formulations were determined by Harlan Laboratories Ltd., Shardlow, UK, Analytical Services. Results show the formulations to be stable for at least nineteen days. Formulations were initially prepared daily for the first week, weekly for the second and final week and fortnightly for the remaining weeks. All formulations were stored at approximately 4 °C in the dark.
Samples of the test item formulation were taken and analyzed for concentration of bis(4-methylbenzoyl)peroxide, 75% CAS No. 895-85-2 in water at Harlan Laboratories Ltd., Shardlow, UK, Analytical Services. The method used for analysis of formulations and the results obtained are given in Appendix 17. The results indicate that the prepared formulations were within ± 6% of the nominal concentration. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The test item concentration in the test samples was determined by high performance liquid chromatography with UV detection (HPLC/UV) using an external standard technique. The test item gave a chromatographic profile of a single peak.
HPLC: Agilent Technologies 1200, incorporating autosampler annd workstation
Column: Zorbax Eclipse XDB C18 (150 x 4.6 mm id)
Column temp: 40°C
Mobile phase: Acetonitrile: water (90:10 v/v)
Flow rate: 1 ml/min
UV detector wavelength: 252 nm
Injection volume: 5 microL
Retention time: ~3 mins
Study samples and storage
Representative samples were dispatched to the analytical laboratories internally (under ambient conditions) and stored at room temperature until analysis.
Discussion
The detection system was found to have acceptable linearity. The analytical procedure had acceptable recoveries of test item in the vehicle. The method of analysis was validated and proved to be suitable for use. - Details on mating procedure:
- i. Groups of twelve male and twelve female animals were treated daily at the appropriate dose level throughout the study (except for females during parturition where applicable). The first day of dosing was designated as Day 1 of the study.
ii. On Day 15, animals were paired on a 1 male: 1 female basis within each dose group for a maximum of fourteen days.
iii. Following evidence of mating (designated as Day 0 post coitum) the males were returned to their original cages and females were transferred to individual cages. - Duration of treatment / exposure:
- Females: Until Day 5 post-partum
Males: 42 days - Frequency of treatment:
- Daily
- Duration of test:
- Day 5 post-partum
- No. of animals per sex per dose:
- 12 males, 12 females per dose group (including Control)
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- The animals were randomly allocated to treatment groups using a stratified body weight randomization procedure and the group mean body weights were then determined to ensure similarity between the treatment groups. The cage distribution within the holding rack was also randomized. The animals were uniquely identified within the study by an ear punching system routinely used in these laboratories.
- Maternal examinations:
- Clinical Observations
All animals were examined for overt signs of toxicity, ill-health and behavioral change immediately before dosing, soon after dosing, and one hour after dosing (except for females during parturition where applicable). All observations were recorded.
Body Weight
Individual body weights were recorded on Day 1 (prior to dosing) and then weekly for males until termination and weekly for females until pairing. During the pairing phase females were weighed daily until mating was confirmed. Body weights were then recorded for females on Days 0, 7, 14 and 20 post coitum, and on Days 1 and 4 post partum.
Food Consumption
During the pre-pairing period, weekly food consumption was recorded for each cage of adults until pairing. This was continued for males after the mating phase. For females showing evidence of mating, food consumption was recorded for the periods covering post coitum Days 0-7, 7-14 and 14-20. For females with live litters, food consumption was recorded during the lactation period (Days 1-4).
Weekly food efficiency (body weight gain/food intake) was calculated retrospectively for males and for females during the pre-pairing phase. Due to offspring growth and milk production for lactation, food efficiency for females could not be accurately calculated during gestation and lactation.
Water Consumption
Water intake was observed daily by visual inspection of water bottles for any overt changes.
Necropsy
Surviving adult females were euthanized by intravenous overdose of a suitable barbiturate agent followed by exsanguination on Day 5 post partum. Surviving offspring were euthanized via intracardiac overdose of a suitable barbiturate agent. Any females which failed to achieve pregnancy or produce a litter were euthanized on or after Day 25 post coitum.
For all females, the uterus was examined for signs of implantation and the number of uterine implantations in each horn was recorded. This procedure was enhanced; as necessary, by staining the uteri with a 0.5% ammonium polysulphide solution (Salewski 1964). The corpora lutea were also counted.
All adult animals and offspring, including those dying during the study, were subjected to a full external and internal examination, and any macroscopic abnormalities were recorded.
Histopathology
Samples of the following tissues were preserved from all animals from each dose group, in buffered 10% formalin, except where stated:
Coagulating gland, Seminal vesicles, Ovaries, Mammary gland, Uterus/Cervix, Pituitary, Vagina
All tissues were dispatched to the histology processing Test Site (Propath UK Ltd, Willow Court, Netherwood Road, Rotherwas, Hereford, HR2 6JU) for processing. The tissues from control and 1000 mg/kg bw/day dose group animals, and any animals which did not achieve a pregnancy were prepared as paraffin blocks, sectioned at a nominal thickness of 5 μm and stained with Hematoxylin and Eosin for subsequent microscopic examination. In addition, sections of testes from all control and 1000 mg/kg bw/day males were also stained with Periodic Acid-Schiff (PAS) stain and examined.
Detailed qualitative examination of the testes was undertaken, taking into account the tubular stages of the spermatogenic cycle. The examination was conducted in order to identify treatment-related effects such as missing germ cell layers or types, retained spermatids, multinucleated or apoptotic germ cells and sloughing of spermatogenic cells into the lumen. Any cell or stage specificity of testicular findings was noted.
Microscopic examination was conducted by the Study Pathologist (Roger Alison Ltd, Caerfyrddin Fach, Cilcennin, Lampeter, SA48 8RN, United Kingdom). - Ovaries and uterine content:
- Pregnancy and Parturition
Each pregnant female was observed at approximately 0830, 1230 and 1630 hours and around the period of expected parturition. Observations were carried out at approximately 0830 and 1230 hours at weekends and public holidays. The following was recorded for each female:
i. Date of pairing
ii. Date of mating
iii. Date and time of observed start of parturition
iv. Date and time of observed completion of parturition - Fetal examinations:
- Litter Data
On completion of parturition (Day 0 post partum), the number of live and dead offspring was recorded. Offspring were individually identified within each litter by tattoo on Day 1 post partum.
For each litter the following was recorded:
i. Number of offspring born
ii. Number of offspring alive recorded daily and reported on Days 1 and 4 post partum
iii. Sex of offspring on Days 1 and 4 post partum
iv. Clinical condition of offspring from birth to Day 5 post partum
v. Individual offspring weights on Days 1 and 4 post partum (litter weights were calculated retrospectively from this data)
Physical Development
All live offspring were assessed for surface righting reflex on Day 1 post partum. - Statistics:
- Please refer to the section below "Any other information on materials and methods"
- Indices:
- Fertility Indices
For each group the following were calculated:
Mating Index (%) = (Number of animals mated / Number of animals paired) x 100
Pregnancy Index (%) = (Number of pregnant females / Number of animals mated) x 100
Gestation and Parturition Data
The following parameters were calculated from individual data during the gestation and parturition period of the parental generation:
i. Gestation Length
Calculated as the number of days of gestation including the day for observation of mating and the start of parturition.
ii. Parturition Index
The following was calculated for each group:
Parturition Index (%) = (Number of females delivering live offspring / Number of pregnant females) x 100
Litter Responses
The standard unit of assessment was considered to be the litter, therefore values were first calculated for each litter and the group mean was calculated using their individual litter values. Group mean values included all litters reared to termination (Day 5 of age).
i. Implantation Losses (%)
Group mean percentile pre-implantation and post-implantation loss were calculated for each female/litter as follows:
Pre–implantation loss (%) = ((Number of corpora lutea - Number of implantation sites) / Number of corpora lutea) x100
Post–implantation loss (%) = ((Number of implantation sites - Total number of offspring born) / Number of implantation sites) x100
ii. Live Birth and Viability Indices
The following indices were calculated for each litter as follows:
Live Birth Index (%) = (Number of offpsring alive on Day 1 / Number of offpsring born) x 100
Viability Index (%) = (Number of offspring alove on Day 4 / Number of offspring alive on Day 1) x 100
iii. Sex Ratio (% males)
Sex ratio was calculated for each litter value on Days 1 and 4 post partum, using the following formula:
(Number of male offspring / Otal number of offpsring) x 100 - Details on maternal toxic effects:
- Maternal toxic effects:no effects
Details on maternal toxic effects:
Mortality
There were no deaths that were considered to be related to treatment.
One female treated with 1000 mg/kg bw/day was found dead shortly after smearing on Day 21. This female had not shown any clinical signs prior to Day 21, no effect on body weight gain and no macroscopic or microscopic abnormalities were evident. This death was therefore considered to be incidental and not related to treatment.
Clinical Observations
There were no toxicologically significant clinical signs evident in treated animals.
One female treated with 1000 mg/kg bw/day had noisy respiration on Day 36 and one female treated with 200 mg/kg bw/day had generalised fur loss between Days 21 and 44.
Body Weight
There were no treatment-related effects on body weight development.
Females treated with 1000 and 50 mg/kg bw/day showed a statistically significant increase in body weight on Day 4 of lactation. An increase in body weight or body weight gain is not considered to represent an adverse effect of treatment therefore the intergroup differences were considered not to be toxicologically important.
Food Consumption
No adverse efeects on dietary intake were noted for females during the pre-pairing, gestation or lactation phases of the study.
Statistical analysis of the data for females during gestation and lactation did not reveal any significant intergroup differences.
Water Consumption
No adverse effect on water consumption was evident in treated animals when compared to controls.
Reproductive Performance
Mating
No treatment-related effects were detected in mating performance.
One control female showed positive evidence of mating but was non pregnant. No histopathological abnormalities were observed to explain the failure of this animal to breed successfully.
Fertility
There were no treatment-related differences in fertility.
One female treated with 50 mg/kg bw/day showed positive evidence of mating but failed to give birth to any live offspring. No histopathological abnormalities were observed to explain the failure of this animal to breed successfully and in the absence of a similar effect at 1000 mg/kg bw/day this was considered incidental and unrelated to treatment.
Gestation Length
Gestation lengths were between 22 and 23½ days and the distribution of gestation lengths for treated females was essentially similar to control.
Pathology
Adults
No macroscopic abnormalities were detected. - Dose descriptor:
- NOEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Basis for effect level:
- other: developmental toxicity
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
In total eleven females from the control, 50 and 1000 mg/kg bw/day dose groups and twelve females from the 200 mg/kg bw/day dose group gave birth to a live litter and successfully reared young to Day 5 of age. The following assessment of litter response is based on all litters reared to termination on Day 5 of lactation/age.
Offspring Litter Size, Sex Ratio and Viability
No significant differences were detected for corpora lutea, implantation counts, implantation losses, litter size or litter viability for treated animals when compared to controls. Statistical analysis of the data did not reveal any significant intergroup differences.
There were no intergroup differences in sex ratio (percentage male offspring) for litters from treated groups compared to controls. Statistical analysis of the data did not reveal any significant intergroup differences.
Offspring Growth and Development
There were no toxicologically significant effects detected.
Statistical analysis of the litter, offspring weights or surface righting reflex data did not reveal any significant intergroup differences.
No obvious clinical signs of toxicity were detected for offspring from treated females when compared to controls. The incidental clinical signs detected throughout the control and treated groups, consisting of small size, cold, physical injury, bruising or scab formation were considered to be low incidence findings observed in offspring in studies of this type and were considered unrelated to test item toxicity.
Necropsy
Offspring
No treatment-related macroscopic abnormalities were detected for offspring. The incidental findings observed were those occasionally observed in reproductive studies of this type and were considered to be unrelated to toxicity of the test item. - Key result
- Dose descriptor:
- NOEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Basis for effect level:
- other: developmental toxicity
- Abnormalities:
- not specified
- Developmental effects observed:
- not specified
- Conclusions:
- The oral administration of bis(4-methylbenzoyl)peroxide, 75% in water CAS No. 895-85-2 to rats by gavage, at dose levels of 50, 200 and 1000 mg/kg bw/day, did not result in any treatment-related effects.
- Executive summary:
Introduction
The study was performed to screen for potential adverse effects of the test item on reproduction, including offspring development, and provides an initial hazard assessment for effect on reproduction. The study is compatible with the requirements of the recommendations of the OECD Guidelines for Testing of Chemicals No. 421 “Reproduction/Developmental Toxicity Screening Test” (adopted 27 July 1995).
This study was also designed to be compatible with Commission Regulation (EC) No 440/2008 of 30 May 2008 test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).
Methods…….
The test item was administered by gavage to three groups, each of twelve male and twelve female Wistar Han™:RccHan™:WIST strain rats, for up to eight weeks (including a two week pre-pairing phase, pairing, gestation and early lactation for females), at dose levels of 50, 200 and 1000 mg/kg bw/day. A control group of twelve males and twelve females was dosed with vehicle alone (Polyethylene glycol 400).
Clinical signs, body weight change, dietary intake and water consumption were monitored during the study.
Pairing of animals within each dose group was undertaken on a one male: one female basis within each treatment group on Day 15 of the study, with females subsequently being allowed to litter and rear their offspring to Day 5 of lactation.
During the lactation phase, daily clinical observations were performed on all surviving offspring, together with litter size and offspring weights and assessment of surface righting reflex.
Adult males were euthanized on Day 43, followed by the euthanization of all surviving females and offspring on Day 5post partum. Any female which did not produce a pregnancy was euthanized on or after Day 25post coitum. All animals were subjected to a gross necropsy examination and histopathological evaluation of reproductive tissues was performed.
Results…….
Adult Responses
Mortality
There were no deaths that were considered to be related to treatment.
Clinical Observations
No toxicologically significant clinical signs were detected in treated animals.
Body Weight
There were no treatment-related effects on body weight development.
Food Consumption
No adverse effects on dietary intake were noted for males during the study or for females during the pre-pairing, gestation or lactation phases of the study.
Water Consumption
No adverse effect on water consumption was evident in treated animals when compared to controls.
Reproductive Performance
Mating
No treatment-related effects were detected in mating performance. One control female showed positive evidence of mating but was non pregnant.
Fertility
There were no treatment-related differences in fertility.
Gestation Length
Gestation lengths were between 22 and 23½ days and the distribution of gestation lengths for treated females was essentially similar to control.
Litter Responses
Offspring Litter Size, Sex Ratio and Viability
Of the litters born, litter size at birth and subsequently on Days 1 and 4post partumwere comparable to controls. Sex ratio in treated litters was comparable to controls.
Offspring Growth and Development
Offspring body weight gain and litter weights at birth and subsequently on Days 1 and 4 post partum were comparable to controls. Surface righting in treated litters was comparable to controls.
Offspring Observations
The clinical signs and necropsy findings apparent for offspring on the study were typical for the age observed. Neither the incidence nor distribution of these observations indicated any adverse effect of maternal treatment on offspring development at 50, 200 or 1000 mg/kg bw/day.
Pathology
Necropsy
No macroscopic abnormalities were detected.
Organ Weights
No treatment-related changes were evident in the organ weights measured.
Histopathology
No treatment-related microscopic abnormalities were detected.
Conclusion
The oral administration of bis(4-methylbenzoyl)peroxide, 75% in water CAS No. 895-85-2 to rats by gavage, at dose levels of 50, 200 and 1000 mg/kg bw/day, did not result in any treatment-related effects.
The ‘No Observed Effect Level’ (NOEL) for reproductive and developmental toxicity was considered to be 1000 mg/kg bw/day.
Reference
The following information relates only to the males used in the study:
Clinical Observations
Two males treated with 1000 mg/kg bw/day and one male treated with 50 mg/kg bw/day showed isolated incidents of increased salivation on Day 29 and 30 (respectively).
Food Consumption
No adverse effects on dietary intake were noted for males during the study.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- Rating: K1 (GLP study)
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Bis(4-methylbenzoyl)peroxide, 75% in water CAS No. 895-85-2:Oral (Gavage) Reproduction/Developmental Toxicity Screening Test in the Rat (OECD 421):
Introduction
The study was performed to screen for potential adverse effects of the test item on reproduction, including offspring development, and provides an initial hazard assessment for effect on reproduction. The study is compatible with the requirements of the recommendations of the OECD Guidelines for Testing of Chemicals No. 421 “Reproduction/Developmental Toxicity Screening Test” (adopted 27 July 1995).
This study was also designed to be compatible with Commission Regulation (EC) No 440/2008 of 30 May 2008 test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).
Methods…….
The test item was administered by gavage to three groups, each of twelve male and twelve female Wistar Han™:RccHan™:WIST strain rats, for up to eight weeks (including a two week pre-pairing phase, pairing, gestation and early lactation for females), at dose levels of 50, 200 and 1000 mg/kg bw/day. A control group of twelve males and twelve females was dosed with vehicle alone (Polyethylene glycol 400).
Clinical signs, body weight change, dietary intake and water consumption were monitored during the study.
Pairing of animals within each dose group was undertaken on a one male: one female basis within each treatment group on Day 15 of the study, with females subsequently being allowed to litter and rear their offspring to Day 5 of lactation.
During the lactation phase, daily clinical observations were performed on all surviving offspring, together with litter size and offspring weights and assessment of surface righting reflex.
Adult males were euthanized on Day 43, followed by the euthanization of all surviving females and offspring on Day 5post partum. Any female which did not produce a pregnancy was euthanized on or after Day 25post coitum. All animals were subjected to a gross necropsy examination and histopathological evaluation of reproductive tissues was performed.
Results…….
Adult Responses
Mortality
There were no deaths that were considered to be related to treatment.
Clinical Observations
No toxicologically significant clinical signs were detected in treated animals.
Body Weight
There were no treatment-related effects on body weight development.
Food Consumption
No adverse effects on dietary intake were noted for males during the study or for females during the pre-pairing, gestation or lactation phases of the study.
Water Consumption
No adverse effect on water consumption was evident in treated animals when compared to controls.
Reproductive Performance
Mating
No treatment-related effects were detected in mating performance. One control female showed positive evidence of mating but was non pregnant.
Fertility
There were no treatment-related differences in fertility.
Gestation Length
Gestation lengths were between 22 and 23½ days and the distribution of gestation lengths for treated females was essentially similar to control.
Litter Responses
Offspring Litter Size, Sex Ratio and Viability
Of the litters born, litter size at birth and subsequently on Days 1 and 4post partumwere comparable to controls. Sex ratio in treated litters was comparable to controls.
Offspring Growth and Development
Offspring body weight gain and litter weights at birth and subsequently on Days 1 and 4 post partum were comparable to controls. Surface righting in treated litters was comparable to controls.
Offspring Observations
The clinical signs and necropsy findings apparent for offspring on the study were typical for the age observed. Neither the incidence nor distribution of these observations indicated any adverse effect of maternal treatment on offspring development at 50, 200 or 1000 mg/kg bw/day.
Pathology
Necropsy
No macroscopic abnormalities were detected.
Organ Weights
No treatment-related changes were evident in the organ weights measured.
Histopathology
No treatment-related microscopic abnormalities were detected.
Conclusion
The oral administration of bis(4-methylbenzoyl)peroxide, 75% in water CAS No. 895-85-2 to rats by gavage, at dose levels of 50, 200 and 1000 mg/kg bw/day, did not result in any treatment-related effects or treatment-related adverse effects.
The ‘No Observed Effect Level’ (NOEL) for reproductive and developmental toxicity was considered to be 1000 mg/kg bw/day.
Justification for selection of Effect on developmental
toxicity: via oral route:
A well-conducted GLP study.
Justification for classification or non-classification
Based on the OECD 421 (Reproduction/Developmental Toxicity Screening) Test in rats, it was concluded that the test substance, under the conditions of this test, did not reveal reproductive or developmental toxicity. These data are conclusive but not sufficient for classification.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)